Inventor
PASQUIER ELISABETH THERESE JEANNE
FR15 patents
⚠️ This page may combine multiple inventors who share the name “PASQUIER ELISABETH THERESE JEANNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
9 patentsUS7902225B2Mar 8, 2011
Mycobacterial inhibitors
JANSSEN PHARMACEUTICA NV17 citations83
US7705148B2Apr 27, 2010
Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
JANSSEN PHARMACEUTICA NV7 citations71
US7563922B2Jul 21, 2009
Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
JANSSEN PHARMACEUTICA NV6 citations71
US7709498B2May 4, 2010
Quinoline derivatives as antibacterial agents
JANSSEN PHARMACEUTICA NV6 citations62
US7790894B2Sep 7, 2010
Mycobacterial inhibitors
JANSSEN PHARMACEUTICA NV6 citations61
US7915292B2Mar 29, 2011
Antibacterial quinoline derivatives
JANSSEN PHARMACEUTICA NV0 citations40
US10202387B2Feb 12, 2019
Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors
JANSSEN PHARMACEUTICA NV0 citations39
US10087187B2Oct 2, 2018
Imidazopyridazine derivatives as PI3KB inhibitors
JANSSEN PHARMACEUTICA NV0 citations39
US10280170B2May 7, 2019
Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives as Ros1 inhibitors
JANSSEN PHARMACEUTICA NV0 citations35